Excimer Laser Coronary Atherectomy (ELCA) is a well-established therapy that emerged for the treatment of peripheral vascular atherosclerosis in the late 1980s, at a time when catheters and materials were rudimentary and associated with the most serious complications. Refinements in catheter technology and the introduction of improved laser techniques have led to their effective use for the treatment of a wide spectrum of complex coronary lesions, such as thrombotic lesions, severe calcific lesions, non-crossable or non-expandable lesions, chronic occlusions, and stent under-expansion. The gradual introduction of high-energy strategies combined with the contrast infusion technique has enabled us to treat an increasing number of complex cases with a low rate of periprocedural complications. Currently, the use of the ELCA has also been demonstrated to be effective in acute coronary syndrome (ACS), especially in the context of large thrombotic lesions.

Golino L., Caiazzo G., Calabro P., Colombo A., Contarini M., Fedele F., et al. (2022). Excimer laser technology in percutaneous coronary interventions: Cardiovascular laser society's position paper. INTERNATIONAL JOURNAL OF CARDIOLOGY, 350, 19-26 [10.1016/j.ijcard.2021.12.054].

Excimer laser technology in percutaneous coronary interventions: Cardiovascular laser society's position paper

Caiazzo G.;Fedele F.;Galassi A. R.;Di Lorenzo E.;Perrotta R.;Pieri D.;
2022

Abstract

Excimer Laser Coronary Atherectomy (ELCA) is a well-established therapy that emerged for the treatment of peripheral vascular atherosclerosis in the late 1980s, at a time when catheters and materials were rudimentary and associated with the most serious complications. Refinements in catheter technology and the introduction of improved laser techniques have led to their effective use for the treatment of a wide spectrum of complex coronary lesions, such as thrombotic lesions, severe calcific lesions, non-crossable or non-expandable lesions, chronic occlusions, and stent under-expansion. The gradual introduction of high-energy strategies combined with the contrast infusion technique has enabled us to treat an increasing number of complex cases with a low rate of periprocedural complications. Currently, the use of the ELCA has also been demonstrated to be effective in acute coronary syndrome (ACS), especially in the context of large thrombotic lesions.
Golino L., Caiazzo G., Calabro P., Colombo A., Contarini M., Fedele F., et al. (2022). Excimer laser technology in percutaneous coronary interventions: Cardiovascular laser society's position paper. INTERNATIONAL JOURNAL OF CARDIOLOGY, 350, 19-26 [10.1016/j.ijcard.2021.12.054].
File in questo prodotto:
File Dimensione Formato  
Excimer laser - position paper.pdf

non disponibili

Tipologia: Versione Editoriale
Dimensione 633.98 kB
Formato Adobe PDF
633.98 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/549113
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact